Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 2/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | HRH2 | P25021 | 2/20 | 0.30 |
| ▸ | HRH1 | P35367 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17356196 | 1.00 | GRIN2B (0.39) | GRIN2BGRIN2CCTSLCTSBCTSK | |
| SCHEMBL17356194 | 0.85 | GRIN2B (0.39) | GRIN2BGRIN2CCTSLCTSBCTSK | |
| SCHEMBL17356207 | 0.85 | GRIN2B (0.39) | GRIN2BGRIN2CCTSLCTSBCTSK | |
| SCHEMBL17356201 | 0.85 | GRIN2B (0.41) | GRIN2BGRIN2CCTSLCTSBCTSK | |
| SCHEMBL17352408 | 0.85 | GRIN2B (0.41) | GRIN2BGRIN2CCTSLCTSBCTSK | |
| SCHEMBL15937236 | 0.84 | BACE1 (0.31) | — | |
| SCHEMBL20329125 | 0.83 | CTSL (0.32) | GRIN2BGRIN2CCTSLCTSBCTSK | |
| SCHEMBL15937231 | 0.83 | CTSL (0.32) | GRIN2BGRIN2CCTSLCTSBCTSK | |
| SCHEMBL19501063 | 0.80 | CTSK (0.38) | GRIN2BGRIN2CCTSLCTSBCTSK | |
| SCHEMBL19501065 | 0.79 | CTSL (0.41) | GRIN2BGRIN2CCTSLCTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016057713-A1 | NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF | SAGE THERAPEUTICS, INC. (US) | 2016-04-14 | — | — | WO | disclosed |